[Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity]

Li-li Zhang1, Qian Ding, Jin-biao Zhan

  • 1Department of Biochemistry and Genetics, College of Medicine, Zhejiang University, Hangzhou 310058, China.

Abstract

Insights

Bitter melon

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Pharmacology

Background:

  • Momordica charantia L. (bitter melon) seeds contain ribosome inactivating proteins (RIPs).
  • MAP30 is a RIP with potential therapeutic applications.
  • Efficient production of bioactive MAP30 is crucial for further research.

Purpose of the Study:

  • To clone and produce recombinant ribosome inactivating protein MAP30 from bitter melon seeds.
  • To assess the biological activity and cytotoxicity of the recombinant MAP30 protein.

Main Methods:

  • Polymerase chain reaction (PCR) and T-A cloning were used to isolate the MAP30 gene.
  • The MAP30 gene was inserted into the pET30a vector for expression in E. coli.
  • Recombinant MAP30 expression was induced using IPTG, and protein activity was evaluated via MTT assay.

Main Results:

  • The cloned MAP30 sequences (nucleotide and amino acid) matched reported sequences.
  • SDS-PAGE confirmed the production of soluble recombinant MAP30.
  • The recombinant MAP30 exhibited higher cytotoxicity towards cancer cells compared to normal cells.

Conclusions:

  • The gene encoding MAP30 was successfully cloned and expressed in E. coli.
  • The recombinant MAP30 protein demonstrated significant bioactivity and selective cytotoxicity.

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...